-
1
A Novel 4-gene Score to Predict Survival, Distant Metastasis and Response to Neoadjuvant Therapy in Breast Cancer
Published 2020-05-01“…The 4-gene score was able to predict worse survival or clinically aggressive tumors, such as high Nottingham pathological grade and advanced cancer staging. High score was associated with worse survival in the hormonal receptor (HR)-positive/Her2-negative subtype. …”
Get full text
Article -
2
Altered Expression of Secreted Mediator Genes That Mediate Aggressive Breast Cancer Metastasis to Distant Organs
Published 2021-05-01“…The gene expression scores predicted worse clinically aggressive tumors, such as high Nottingham histological grade and advanced cancer staging. Higher gene expression score of ESM-1 gene was strongly associated with worse overall survival (OS) in the triple-negative breast cancer (TNBC) and hormonal receptor (HR)-positive/HER2-negative subtype in METABRIC cohort, HER2+ subtype in TCGA-BRCA and SCAN-B breast cancer cohorts. …”
Get full text
Article -
3
Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study
Published 2021-12-01“…Post‐surgery pathological diagnosis was the reference standard and breast cancer staging followed the TNM classification. There was no restriction on disease stage for eligibilities. …”
Get full text
Article -
4
The Unfolded Protein Response Is Associated with Cancer Proliferation and Worse Survival in Hepatocellular Carcinoma
Published 2021-09-01“…Enhanced UPR was associated with the clinical parameters of HCC progression, such as cancer stage and multiple parameters of cell proliferation, including histological grade, mKI67 gene expression, and enrichment of cell proliferation-related gene sets. …”
Get full text
Article -
5
Plasma Sphingosine-1-Phosphate Levels Are Associated with Progression of Estrogen Receptor-Positive Breast Cancer
Published 2021-12-01“…Plasma S1P levels were also significantly higher in patients with larger tumor size (<i>p</i> = 0.012), lymph node metastasis (<i>p</i> = 0.014), and advanced cancer stage (<i>p</i> = 0.003), suggesting that higher levels of plasma S1P are associated with cancer progression. …”
Get full text
Article